论文信息 - Pembrolizumab KEYNOTE-001: an adaptive study leading to accelerated approval for two indications and a companion diagnostic - 字舞流文

Pembrolizumab KEYNOTE-001: an adaptive study leading to accelerated approval for two indications and a companion diagnostic

D. D. de Alwis | E. Rubin | G. Lubiniecki | S. Kang | Cong Chen | K. Gergich | C. Chen | S. P. Kang | M. Tice | S. Kang | S. Kang | D. D. Alwis | S. Kang | S. Kang | S. Kang